These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31153793)

  • 1. The implications and management of cystic fibrosis screen positive, inconclusive diagnosis patients.
    Krishnananthan T; Pao C
    Paediatr Respir Rev; 2019 Aug; 31():21-24. PubMed ID: 31153793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening.
    Munck A; Bourmaud A; Bellon G; Picq P; Farrell PM;
    Pediatr Pulmonol; 2020 Apr; 55(4):918-928. PubMed ID: 31916691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Cystic Fibrosis Screening-Positive Infants With Inconclusive Diagnosis at School Age.
    Gonska T; Keenan K; Au J; Dupuis A; Chilvers MA; Burgess C; Bjornson C; Fairservice L; Brusky J; Kherani T; Jober A; Kosteniuk L; Price A; Itterman J; Morgan L; Mateos-Corral D; Hughes D; Donnelly C; Smith MJ; Iqbal S; Arpin J; Reisman J; Hammel J; van Wylick R; Derynck M; Henderson N; Solomon M; Ratjen F
    Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34814176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis.
    Ren CL; Borowitz DS; Gonska T; Howenstine MS; Levy H; Massie J; Milla C; Munck A; Southern KW
    J Pediatr; 2017 Feb; 181S():S45-S51.e1. PubMed ID: 28129812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID).
    Barben J; Castellani C; Munck A; Davies JC; de Winter-de Groot KM; Gartner S; Kashirskaya N; Linnane B; Mayell SJ; McColley S; Ooi CY; Proesmans M; Ren CL; Salinas D; Sands D; Sermet-Gaudelus I; Sommerburg O; Southern KW;
    J Cyst Fibros; 2021 Sep; 20(5):810-819. PubMed ID: 33257262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic Fibrosis screen positive, inconclusive diagnosis (CFSPID) to Cystic Fibrosis: Detecting disease with serial assessments.
    Manzoor J; Hughes DA
    Paediatr Respir Rev; 2023 Sep; 47():19-22. PubMed ID: 37365112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn screening for cystic fibrosis: Is there benefit for everyone?
    Course CW; Hanks R
    Paediatr Respir Rev; 2019 Aug; 31():3-5. PubMed ID: 30956155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of CFTR-related disorders and cystic fibrosis in an Italian cohort of CRMS/CFSPID subjects in preschool and school age.
    Fevola C; Dolce D; Tosco A; Padoan R; Daccò V; Claut L; Schgor T; Sepe A; Timpano S; Fabrizzi B; Piccinini P; Taccetti G; Bonomi P; Terlizzi V
    Eur J Pediatr; 2024 Feb; 183(2):929-938. PubMed ID: 38054992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of the French cystic fibrosis newborn screening programme by a centralized tracking process.
    Munck A; Delmas D; Audrézet MP; Lemonnier L; Cheillan D; Roussey M
    J Med Screen; 2018 Mar; 25(1):6-12. PubMed ID: 28454512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-classic cystic fibrosis associated with D1152H CFTR mutation.
    Burgel PR; Fajac I; Hubert D; Grenet D; Stremler N; Roussey M; Siret D; Languepin J; Mely L; Fanton A; Labbé A; Domblides P; Vic P; Dagorne M; Reynaud-Gaubert M; Counil F; Varaigne F; Bienvenu T; Bellis G; Dusser D
    Clin Genet; 2010 Apr; 77(4):355-64. PubMed ID: 19843100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders.
    Pagin A; Sermet-Gaudelus I; Burgel PR
    Arch Pediatr; 2020 Feb; 27 Suppl 1():eS25-eS29. PubMed ID: 32172933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres.
    Terlizzi V; Claut L; Tosco A; Colombo C; Raia V; Fabrizzi B; Lucarelli M; Angeloni A; Cimino G; Castaldo A; Marsiglio L; Timpano S; Cirilli N; Moroni L; Festini F; Piccinini P; Zavataro L; Bonomi P; Taccetti G; Southern KW; Padoan R
    J Cyst Fibros; 2021 Sep; 20(5):828-834. PubMed ID: 33883100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification.
    Salinas DB; Ginsburg DK; Wee CP; Saeed MM; Brewington JJ
    Pediatr Pulmonol; 2023 Apr; 58(4):1074-1084. PubMed ID: 36582049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is cystic fibrosis screen positive inconclusive diagnosis? And what is it not?
    Devoy E; Hughes D; Alharbi AF; Francis J; Davies JC
    Arch Dis Child Educ Pract Ed; 2024 Sep; 109(5):237-241. PubMed ID: 38453427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of early repeat sweat testing in infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/CF screen-positive, inconclusive diagnosis.
    Terlizzi V; Claut L; Colombo C; Tosco A; Castaldo A; Fabrizzi B; Lucarelli M; Cimino G; Carducci C; Dolce D; Biffi A; Bonomi P; Timpano S; Padoan R
    Pediatr Pulmonol; 2021 Dec; 56(12):3785-3791. PubMed ID: 34549893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis.
    Ooi CY; Sutherland R; Castellani C; Keenan K; Boland M; Reisman J; Bjornson C; Chilvers MA; van Wylick R; Kent S; Price A; Mateos-Corral D; Hughes D; Solomon M; Zuberbuhler P; Brusky J; Durie PR; Ratjen F; Gonska T
    BMC Pediatr; 2019 Oct; 19(1):369. PubMed ID: 31640630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inconclusive diagnosis of cystic fibrosis after newborn screening.
    Ooi CY; Castellani C; Keenan K; Avolio J; Volpi S; Boland M; Kovesi T; Bjornson C; Chilvers MA; Morgan L; van Wylick R; Kent S; Price A; Solomon M; Tam K; Taylor L; Malitt KA; Ratjen F; Durie PR; Gonska T
    Pediatrics; 2015 Jun; 135(6):e1377-85. PubMed ID: 25963003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
    Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
    Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis newborn screening: outcome of infants with normal sweat tests.
    Edmondson C; Grime C; Prasad A; Cowlard J; Nwokoro CEC; Ruiz G; Wallis C; Balfour-Lynn IM
    Arch Dis Child; 2018 Aug; 103(8):753-756. PubMed ID: 29113966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry.
    Salinas DB; Wee CP; Bailey B; Raraigh K; Conrad D
    Ann Am Thorac Soc; 2023 Apr; 20(4):523-531. PubMed ID: 36409994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.